On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with ...
Oct 23 (Reuters) - The U.S. Food and Drug Administration has approved British drugmaker GSK's (GSK.L), opens new tab blood cancer drug, Blenrep, in one combination regimen, the company said on ...
On October 9, 2025, the FDA approved Celltrion’s aflibercept biosimilar, EYDENZELT® (aflibercept-boav) referencing Regeneron’s EYLEA® (aflibercept). This approval makes Celltrion the sixth company to ...
– FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data – – Gazyva is the only anti-CD20 monoclonal antibody to demonstrate ...
The logo of Bayer Mexico is pictured at the company's plant in Lerma, Mexico November 10, 2022. REUTERS/Henry Romero (Reuters) -Germany's Bayer said on Friday the U.S. health regulator has approved ...
Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with nasal polyps (CRSwNP), a second biologic therapy has broken through with a ...
London — Thousands of people in the United Kingdom have filed a joint legal claim estimated to be worth more than £1 billion ($1.34 billion) against Johnson & Johnson, accusing the U.S. pharmaceutical ...
Shares of Johnson & Johnson were rising into record territory in early trading Tuesday, after the medicines and medical-technology giant beat quarterly earnings expectations and raised its outlook, ...
Dakota Johnson reveals ‘scary’ childhood in spotlight as Melanie Griffith and Don Johnson’s daughter
Growing up with famous parents, Melanie Griffith, Don Johnson and stepfather Antonio Banderas, left an indelible mark on Dakota Johnson — sometimes for the better and sometimes not. “I don’t think I ...
Teva Pharmaceuticals and Medincell have gained approval from the US Food and Drug Administration (FDA) for Uzedy (risperidone), a once-a-month extended-release injectable suspension to treat adult ...
Good morning, and welcome to Johnson & Johnson's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results